Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Urology Service, Fundacion Arturo Lopez Perez, Santiago, Chile.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
J Urol. 2016 Aug;196(2):507-13. doi: 10.1016/j.juro.2016.02.080. Epub 2016 Feb 22.
We describe the efficacy of radical prostatectomy to achieve complete primary tumor excision while preserving erectile function in a cohort of patients with high risk features in whom surgical resection was tailored according to clinical staging, biopsy data, preoperative imaging and intraoperative findings.
In a retrospective review we identified 584 patients with high risk features (prostate specific antigen 20 ng/ml or greater, clinical stage T3 or greater, preoperative Gleason grade 8-10) who underwent radical prostatectomy between 2006 and 2012. The probability of neurovascular bundle preservation was estimated based on preoperative characteristics. Positive surgical margin rates and erectile function recovery were determined in patients who had some degree of neurovascular bundle preservation.
The neurovascular bundles were resected bilaterally in 69 (12%) and unilaterally in 91 (16%) patients. The remaining patients had some degree of bilateral neurovascular bundle preservation. Preoperative features associated with a lower probability of neurovascular bundle preservation were primary biopsy Gleason grade 5 and clinical stage T3 disease. Among the patients with some degree of neurovascular bundle preservation 125 of 515 (24%) had a positive surgical margin, and 75 of 160 (47%) men with preoperatively functional erections and available erectile function followup had recovered erectile function within 2 years.
High risk features should not be considered an indication for complete bilateral neurovascular bundle resection. Some degree of neurovascular bundle preservation can be done safely by high volume surgeons in the majority of these patients with an acceptable rate of positive surgical margins. Nearly half of high risk patients with functional erections preoperatively recover erectile function after radical prostatectomy.
我们描述了根治性前列腺切除术在一组高危特征患者中的疗效,这些患者根据临床分期、活检数据、术前影像学和术中发现,对手术切除进行了个体化设计,以实现肿瘤的完全切除并保留勃起功能。
在一项回顾性研究中,我们确定了 584 例具有高危特征(前列腺特异性抗原 20ng/ml 或更高、临床分期 T3 或更高、术前 Gleason 分级 8-10)的患者,他们在 2006 年至 2012 年间接受了根治性前列腺切除术。根据术前特征估计保留神经血管束的概率。在有一定程度神经血管束保留的患者中,确定切缘阳性率和勃起功能恢复情况。
69 例(12%)患者双侧神经血管束被切除,91 例(16%)患者单侧神经血管束被切除。其余患者有一定程度的双侧神经血管束保留。与保留神经血管束概率较低相关的术前特征是初级活检 Gleason 分级 5 和临床分期 T3 疾病。在有一定程度神经血管束保留的患者中,515 例中有 125 例(24%)存在切缘阳性,160 例术前有勃起功能且有勃起功能随访的患者中,有 75 例(47%)在 2 年内恢复了勃起功能。
高危特征不应被视为完全双侧神经血管束切除的指征。高容量外科医生在大多数此类患者中可以安全地进行一定程度的神经血管束保留,切缘阳性率可接受。近一半术前有勃起功能的高危患者在接受根治性前列腺切除术后恢复了勃起功能。